An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
Clinical trial NCT06238401 · RECRUITING
Trial details
- NCT number
- NCT06238401
- Sponsor
- Hangzhou Adcoris Biopharmacy Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-29
- Primary completion
- 2026-05-30
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.